Teal Ventures

Cooler Heads is a company that specializes in developing portable scalp cooling systems specifically for chemotherapy patients. Its flagship product, Amma™, is designed to help individuals undergoing cancer treatment maintain their hair, thereby enhancing their sense of identity and control during a challenging time. By cooling the scalp, the system aims to reduce hair loss associated with chemotherapy, allowing patients to manage the physical side effects of treatment more effectively. This approach not only addresses the cosmetic concerns of hair loss but also positively impacts patients' mental health and overall recovery by supporting their emotional well-being throughout the treatment process.

Nudj Health is a mental health care center focused on integrating lifestyle wellness into patient care. It provides comprehensive, continuous support for individuals with chronic diseases, extending care beyond traditional medical settings. The organization employs a collaborative care model that utilizes evidence-based, Medicare-approved pathways, emphasizing interconnected lifestyle factors to improve patient outcomes. By enhancing care coordination, Nudj Health aims to boost patient satisfaction while reducing reliance on acute and outpatient services.

Nudj Health is currently operating in stealth mode.

Diagenta is a healthcare company that specializes in telehealth and patient monitoring services. It has developed a comprehensive platform that facilitates on-demand healthcare delivery, including rapid triage services that assess patient needs and direct them to appropriate care. The platform offers hospital-grade capabilities accessible from patients' homes, thereby reducing the burden on overcrowded facilities and minimizing wait times. Additionally, Diagenta connects patients with medical practitioners through house calls, utilizing an electronic health record system and a suite of diagnostic and treatment tools. This innovative approach allows patients to experience the functionality of a doctor's office and clinical testing lab in a compact, wirelessly connected format, all supervised in real-time by licensed healthcare professionals.

NoniGenex is a company focused on developing disease testing kits that measure neutralizing antibodies. Its primary product allows users to assess their protection against COVID-19, facilitating the detection and management of harmful diseases. By providing reliable testing solutions, NoniGenex aims to contribute to public health efforts in monitoring and responding to infectious diseases.

Cooler Heads is a company that specializes in developing portable scalp cooling systems specifically for chemotherapy patients. Its flagship product, Amma™, is designed to help individuals undergoing cancer treatment maintain their hair, thereby enhancing their sense of identity and control during a challenging time. By cooling the scalp, the system aims to reduce hair loss associated with chemotherapy, allowing patients to manage the physical side effects of treatment more effectively. This approach not only addresses the cosmetic concerns of hair loss but also positively impacts patients' mental health and overall recovery by supporting their emotional well-being throughout the treatment process.

Physician Retraining and Reentry (PRR) provides an online educational program in collaboration with the University of California San Diego School of Medicine, aimed at addressing the increasing physician shortage in the United States. The platform is designed to retrain and re-educate long-tenured physicians, offering online modules that cover essential topics such as cardiology, dermatology, and medical record management. By equipping experienced doctors with the necessary knowledge and skills, PRR facilitates their transition back into practice as primary care physicians, ultimately enhancing healthcare accessibility and quality.

19Labs, Inc. is a healthcare technology company that specializes in telehealth solutions and remote patient management. Founded in 2015 and based in Redwood City, California, with an additional office in Brentwood Bay, Canada, the company offers a range of products under the GALE brand. These include GALE Telehealth 2.0, a comprehensive point-of-care solution, GALE FLORENCE, a compact telehealth unit equipped for first aid supplies and diagnostic devices, GALE MINI, a portable collection of diagnostic tools, and GALE MAX, a tabletop kiosk designed for medical offices. These products enable patients to connect virtually with healthcare providers through video calls, facilitate immediate assistance from on-call practitioners, and allow for real-time sharing of diagnostic readings. 19Labs serves consumers, healthcare providers, and employers, aiming to enhance access to medical care, particularly in home settings and rural areas.

Trials.ai operates an innovative online platform that streamlines the management of clinical trials for life science organizations. Founded in 2016 and based in San Diego, California, the platform integrates various functionalities, including electronic data capture (EDC), clinical trial management systems (CTMS), electronic patient-reported outcomes (ePRO), and analytics, into a single system. This comprehensive approach aids researchers in efficiently navigating trial protocols, managing patient eligibility, scheduling visits, and tracking essential events. Leveraging artificial intelligence, Trials.ai's Smart Protocol system enhances trial design by analyzing extensive data from its codified clinical trials database, providing insights that help trial sponsors optimize their protocols for greater speed and success. By addressing the challenges posed by siloed data and inefficient designs, Trials.ai aims to accelerate the delivery of effective treatments to patients, ultimately reducing the high costs and failures associated with clinical trials.

NeuraLace Medical, Inc. is a technology company based in San Diego, California, founded in 2016. The company specializes in developing a hardware-based neuromodulation platform aimed at managing neuropathic pain through direct and selective stimulation of sensory nerve fibers. NeuraLace offers a non-invasive treatment system that provides significant and sustained relief from chronic nerve pain without the use of opioids. By utilizing short bursts of magnetic pulses to stimulate damaged nerves, the company's innovative approach allows for effective pain management in clinic settings, thereby reducing the risks associated with addiction to pain medications and surgical complications.

FEMSelect Inc. specializes in designing and developing surgical systems and devices for pelvic floor ligament fixation, focusing on women's health. The company is known for its innovative EnPlace system, a minimally invasive and mesh-free solution for treating pelvic organ prolapse (POP). This patented technology allows for precise guidance and deployment of an anchor unit that stabilizes the pelvic floor ligament through a vaginal approach, significantly enhancing patient recovery and comfort. The procedure typically takes about 30 minutes and does not require overnight hospital stays or result in visible scarring. Founded in 2012, FEMSelect operates from its headquarters in Newark, Delaware.